These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 2102614)

  • 1. Protein C and fibrinolysis: a link between coagulation and fibrinolysis.
    de Fouw NJ; Haverkate F; Bertina RM
    Adv Exp Med Biol; 1990; 281():235-43. PubMed ID: 2102614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated protein C accelerates clot lysis by virtue of its anticoagulant activity.
    de Fouw NJ; van Tilburg NH; Haverkate F; Bertina RM
    Blood Coagul Fibrinolysis; 1993 Apr; 4(2):201-10. PubMed ID: 8388739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent.
    Bajzar L; Nesheim ME; Tracy PB
    Blood; 1996 Sep; 88(6):2093-100. PubMed ID: 8822928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro.
    de Fouw NJ; Haverkate F; Bertina RM; Koopman J; van Wijngaarden A; van Hinsbergh VW
    Blood; 1986 Apr; 67(4):1189-92. PubMed ID: 2937472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An antifibrinolytic effect associated with an anti-factor V antibody in a patient with severe thrombophilia.
    Colucci M; Simioni P; Piro D; Prandoni P; Pagnan A; Semeraro N
    Haematologica; 2003 Dec; 88(12):1383-9. PubMed ID: 14687992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor--no evidence for a cofactor role of protein S.
    de Fouw NJ; de Jong YF; Haverkate F; Bertina RM
    Thromb Haemost; 1988 Oct; 60(2):328-33. PubMed ID: 2975409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
    Morishima Y; Honda Y
    J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots.
    Prager NA; Abendschein DR; McKenzie CR; Eisenberg PR
    Circulation; 1995 Aug; 92(4):962-7. PubMed ID: 7641380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
    Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
    J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of activated protein C on fibrinolysis in cell-free plasma can be attributed specifically to attenuation of prothrombin activation.
    Bajzar L; Nesheim M
    J Biol Chem; 1993 Apr; 268(12):8608-16. PubMed ID: 8473306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antifibrinolytic mechanism describing the prothrombotic effect associated with factor VLeiden.
    Bajzar L; Kalafatis M; Simioni P; Tracy PB
    J Biol Chem; 1996 Sep; 271(38):22949-52. PubMed ID: 8798478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor.
    Sakata Y; Loskutoff DJ; Gladson CL; Hekman CM; Griffin JH
    Blood; 1986 Dec; 68(6):1218-23. PubMed ID: 3096399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
    Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V
    Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ; Eisenberg PR; Abendschein DR
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):7-13. PubMed ID: 8457655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the endothelial protein C receptor on thrombin generation and clot lysis.
    Pepler L; Wu C; Dwivedi DJ; Wu C; Kim PY; Liaw PC
    Thromb Res; 2017 Apr; 152():30-37. PubMed ID: 28219843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effect of a direct oral anticoagulant edoxaban and an inhibitor of activated thrombin-activatable fibrinolysis inhibitor on clot lysis.
    Morishima Y; Kamisato C; Honda Y
    J Thromb Thrombolysis; 2020 Jan; 49(1):94-99. PubMed ID: 31396790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin.
    Colucci M; Pentimone A; Binetti BM; Cramarossa M; Piro D; Semeraro N
    Thromb Haemost; 2002 Aug; 88(2):282-7. PubMed ID: 12195701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bidirectional functions of thrombin on fibrinolysis: Evidence of thrombin-dependent enhancement of fibrinolysis provided by spontaneous plasma clot lysis.
    Tomczyk M; Suzuki Y; Sano H; Brzoska T; Tanaka H; Urano T
    Thromb Res; 2016 Jul; 143():28-33. PubMed ID: 27179129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.